Actively Recruiting
SBRT Technique Implementation for Spinal Metastases Irradiation
Led by Institute of Oncology Ljubljana · Updated on 2026-02-24
100
Participants Needed
2
Research Sites
269 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Stereotactic body radiotherapy (SBRT) is a highly precise, image-guided radiotherapy technique delivering 1-5 high-dose fractions to spinal metastases. Compared with conventional radiotherapy, SBRT enables delivery of a higher biologically effective dose while maintaining high precision. The Institute of Oncology Ljubljana initiated spinal SBRT treatments in 2017 and introduced an institutional SBRT spine protocol in 2019. As SBRT is technically demanding, strict adherence to standardized planning and delivery procedures is essential to ensure treatment quality and patient safety. This clinical program aims to support structured implementation and continuous development of the institutional SBRT spine protocol in routine clinical practice. The study prospectively evaluates treatment-related toxicity and local tumor control following SBRT for spinal metastases in order to monitor treatment safety and effectiveness within the institutional program.
CONDITIONS
Official Title
SBRT Technique Implementation for Spinal Metastases Irradiation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients (≥18 years) with spinal metastases or spinal tumors referred for stereotactic body radiotherapy (SBRT).
- Patients eligible for SBRT treatment according to the institutional SBRT spine protocol.
- Ability to undergo CT simulation, immobilization, and image-guided radiotherapy procedures.
You will not qualify if you...
- Inability to tolerate SBRT positioning or immobilization.
- Clinical situations requiring urgent surgical intervention or alternative treatment.
- Other medical conditions that prevent safe SBRT delivery.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Institute of Oncology
Ljubljana, Slovenia, 1000
Actively Recruiting
2
Institute of Oncology Ljubljana
Ljubljana, Slovenia, SI-1000
Actively Recruiting
Research Team
J
Jasna But Hadžić, MD
CONTACT
K
Klavdija Korošec
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here